Voronoi Inc
KOSDAQ:310210
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Voronoi Inc
KOSDAQ:310210
|
KR |
|
C
|
CAB Cakaran Corporation Bhd
KLSE:CARLSBG
|
MY |
|
A
|
Asian Capital Resources (Holdings) Ltd
HKEX:8025
|
HK |
|
A
|
Anheuser-Busch Inbev SA
JSE:ANH
|
BE |
|
Hanwang Technology Co Ltd
SZSE:002362
|
CN |
|
J
|
Jumbo SA
ATHEX:BELA
|
GR |
|
Lime Technologies AB (publ)
STO:LIME
|
SE |
|
Mutoh Holdings Co Ltd
TSE:7999
|
JP |
|
Sietel Ltd
ASX:SSL
|
AU |
|
Eastern Bankshares Inc
NASDAQ:EBC
|
US |
Voronoi Inc
Voronoi, Inc. engages in the manufacture of novel kinase inhibitors and target protein degrader drugs. The company is headquartered in Incheon, Incheon. The company went IPO on 2022-06-24. The firm is principally engaged in the technology transfer of new drug candidates prior to electroclinical clinical trials. The firm is principally engaged in the research and development of kinase inhibitor as well as others. In addition, the Company is also engaged in the building and supply of new drug development platforms based on artificial intelligence (AI) and research results.
Voronoi, Inc. engages in the manufacture of novel kinase inhibitors and target protein degrader drugs. The company is headquartered in Incheon, Incheon. The company went IPO on 2022-06-24. The firm is principally engaged in the technology transfer of new drug candidates prior to electroclinical clinical trials. The firm is principally engaged in the research and development of kinase inhibitor as well as others. In addition, the Company is also engaged in the building and supply of new drug development platforms based on artificial intelligence (AI) and research results.
